Abstract. Reactive oxygen species (ROS) influence the signaling of mitogen-activated protein kinases (MAPKs) involved in cell survival and death. In the present study, the toxicological effect of hydrogen 
Introduction
Reactive oxygen species (ROS) are a group of oxygen moieties that are formed by the incomplete one-electron reduction of oxygen. The major ROS include hydrogen peroxide (H 2 O 2 ), superoxide anion radical (O 2
•-) and hydroxyl radical (
• OH). Among ROS, H 2 O 2 diffuses freely over cell membranes prior to reacting with specific molecular targets due to its solubility in both lipid and aqueous environments and its fairly low reactivity. O 2 •-is metabolized to H 2 O 2 by superoxide dismutases (1) . H 2 O 2 is further detoxified to O 2 and H 2 O by catalase or glutathione (GSH) (2) .
ROS might affect the activity of mitogen-activated protein kinases (MAPKs), which are involved in important signaling pathways in cell proliferation, differentiation and cell death in response to a variety of stimuli (3, 4) . The decision to proliferate, arrest or die depends on the relative strengths of cell survival and apoptotic signals triggered by ROS. The three main signaling modules of MAPKs are the extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) and p38, which has emerged as an important signaling pathway from the membrane to nucleus (3). Each MAPK pathway has different upstream activators and the activated MAPKs promote differential transcriptional stimulation of multiple genes via the phosphorylation of unambiguous transcription factors (5) . MAPKs also sense the cellular redox status and are common targets for ROS. JNK and p38 are mainly activated by ROS or a mild oxidative shift, initiating procedures related to apoptosis (6, 7) . However, the two kinases differentially affect the levels of apoptosis (8) . ROS also provoke or inhibit ERK pathway (9, 10) . In most cases, ERK activation has been shown to have a pro-survival rather than a pro-apoptotic effect (11) . In addition, MAPK pathways are also activated by the direct inhibition of MAPK phosphatases by ROS. Since opposite effects of MAPKs by various ROS can occur in cells, the association between ROS and MAPKs needs to be further elucidated, particularly signaling pathways related to cell survival and death.
Cervical neoplasia is the major cause of cancer-related death in women worldwide. The carcinogenesis of cervical cancer is associated with excessive inflammation mediated by ROS. Tissue concentrations of H 2 O 2 during inflammation can reach millimolar levels, while small amounts of H 2 O 2 produced by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase have been suggested to affect the microenvironments of the plasma membrane (12, 13 Thus, in the present study, the effects of exogenous H 2 O 2 on the cell growth and death of human cervical adenocarcinoma HeLa cells were investigated. The effects of various MAPK inhibitors, including N-acetyl cysteine (NAC) and propyl gallate (PG) (well-known antioxidants), and L-buthionine sulfoximine (BSO; an inhibitor of GSH synthesis), were also evaluated in H 2 O 2 -treated HeLa cells with respect to cell growth and death, as well as ROS and GSH levels.
Materials and methods
Cell culture. Human cervical adenocarcinoma HeLa cells were obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA) and maintained in a humidified incubator containing 5% CO 2 at 37˚C. The cells were cultured in RPMI-1640 medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich) and 1% penicillin-streptomycin (Gibco-BRL, Grand Island, NY, USA). The cells were then routinely grown in 100-mm plastic tissue culture dishes (Nunc A/S, Roskilde, Denmark) and harvested with a solution of trypsin-EDTA while in a logarithmic phase of growth.
Reagents. H 2 O 2 was purchased from Sigma-Aldrich. JNK (SP600125), MEK (PD98059) and p38 inhibitors (SB203580) were purchased from Calbiochem (San Diego, CA, USA). The inhibitors were dissolved in Dulbecco's modified Eagle's medium (DMSO) at 10 mM as a stock solution. NAC, PG and BSO were obtained from Sigma-Aldrich. NAC was dissolved in 20 mM HEPES buffer (pH 7.0), PG was dissolved in ethanol at 200 mM as a stock solution and BSO was dissolved in water. Based on previous studies (8, 14) , the cells were pretreated with 10 µM of each MAPK inhibitor, 2 mM NAC, 100 µM PG or 10 µM BSO for 1 h prior to treatment with H 2 O 2 . Ethanol (0.2%) and DMSO (0.2%) were used as a control vehicle and they did not affect cell growth or death.
Cell growth assays. Cell growth changes were determined by measuring 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra zolium bromide dye (MTT; Sigma-Aldrich) absorbance in living cells as previously described (15) . Briefly, 4x10 4 cells/well were seeded in 96-well microtiter plates (Nunc A/S). Following exposure to 100 µM H 2 O 2 for 24 h in the presence or absence of 10 µM of each MAPK inhibitor (2 mM NAC, 100 µM PG or 10 µM BSO) MTT solution [20 µl: 2 mg/ml in phosphate-buffered saline (PBS)] was added to each well of the 96-well plates. The plates were incubated for 4 h at 37˚C. Medium was withdrawn from the plates by pipetting and 200 µl DMSO was added to each well to solubilize the formazan crystals. Optical density was measured at 570 nm using a microplate reader (Synergy™ 2; BioTek Instruments Inc., Winooski, VT, USA).
Cell cycle and sub-G1 analysis. Cell cycle and sub-G1 analysis were determined by propidium iodide (PI, Ex/Em=488/617 nm; Sigma-Aldrich) staining as previously described (16) . Briefly, 1x10
6 cells in 60-mm culture dishes (Nunc A/S) were incubated with 100 µM H 2 O 2 for 24 h in the presence or absence of 10 µM of each MAPK inhibitor, 2 mM NAC, 100 µM PG or 10 µM BSO. Total cells, including floating cells, were then washed with PBS and fixed in 70% (v/v) ethanol. The cells were washed again with PBS, and then incubated with PI (10 µg/ml) with simultaneous RNase treatment at 37˚C for 30 min. Cellular DNA content was measured using a FACStar flow cytometer (Becton-Dickinson, Franklin Lakes, NJ, USA) and analyzed using Lysis II and CellFit software (Becton-Dickinson).
Annexin V-fluorescein isothiocyanate (FITC) staining for cell death detection. Apoptotic cell death was determined by staining the cells with Annexin V-FITC (Ex/Em=488/519 nm; Invitrogen Life Technologies, Camarillo, CA, USA) as previously described (17) . Briefly, 1x10 6 cells in 60-mm culture dishes were incubated with 100 µM H 2 O 2 for 24 h in the presence or absence of 10 µM of each MAPK inhibitor, 2 mM NAC, 100 µM PG or 10 µM BSO. The cells were washed twice with cold PBS and then resuspended in 500 µl binding buffer (10 mM HEPES/NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) at a concentration of 1x10 6 cells/ml. Annexin V-FITC (5 µl) was then added, and the cells were analyzed with a FACStar flow cytometer.
Measurement of the mitochondrial membrane potential (MMP; ΔΨ m )
. MMP (ΔΨ m ) levels were measured using a rhodamine 123 fluorescent dye (Sigma-Aldrich; Ex/Em=485/535 nm) as described previously (17, 18) . Briefly, 1x10 6 cells in 60-mm culture dishes were incubated with 100 µM H 2 O 2 for 24 h in the presence or absence of 10 µM of each MAPK inhibitor, 2 mM NAC, 100 µM PG or 10 µM BSO. The cells were washed twice with PBS and incubated with rhodamine 123 (0.1 µg/ml) at 37˚C for 30 min. Rhodamine 123 staining intensity was determined using a FACStar flow cytometer. Rhodamine 123-negative cells were characterized by loss of MMP (ΔΨ m ).
Detection of the intracellular ROS levels. Intracellular ROS levels were detected using an oxidation-sensitive fluorescent probe dye, 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA, Ex/Em=495/529 nm; Invitrogen Life Technologies) and dihydroethidium (DHE, Ex/Em=518/605 nm; Invitrogen Life Technologies) as previously described (17, 19) . DHE is highly selective for O 2
•-among ROS. Briefly, 1x10 6 cells/ml in FACS tube (Becton-Dickinson) were treated with 100 µM H 2 O 2 with or without 10 µM of each MAPK inhibitor in the presence of 20 µM H 2 DCFDA or DHE. The levels of DCF and DHE fluorescence dyes were evaluated using a FACStar flow cytometer at 1 h of treatment. DCF (ROS) and DHE (O 2
•-) levels were expressed as mean fluorescence intensity (MFI), which was calculated using CellQuest software (Becton-Dickinson). Moreover, 1x10
6 cells in 60-mm culture dishes (Nunc A/S) were incubated with 100 µM H 2 O 2 for 24 h in the presence or absence of 10 µM of each MAPK inhibitor, 2 mM NAC, 100 µM PG or 10 µM BSO. The cells were then incubated with 20 µM H 2 DCFDA or DHE at 37˚C for 30 min. H 2 DCFDA or DHE fluorescence was assessed using a FACStar flow cytometer.
Detection of the intracellular GSH. Cellular GSH levels were analyzed using a 5-chloromethylfluorescein diacetate dye (CMFDA, Ex/Em=522/595 nm; Invitrogen Life Technologies) as previously described (19, 20) . Briefly, 1x10
6 cells/ml in FACS tube were treated with 100 µM H 2 O 2 with or without 10 µM of each MAPK inhibitor in the presence of 5 µM CMFDA. The levels of CMF fluorescence were evaluated using a FACStar flow cytometer at 1 h of treatment. CMF (GSH) levels were expressed as MFI, which was calculated using CellQuest software. In addition, 1x10 6 cells in 60-mm culture dishes (Nunc A/S) were incubated with 100 µM H 2 O 2 for 24 h in the presence or absence of 10 µM of each MAPK inhibitor, 2 mM NAC, 100 µM PG or 10 µM BSO. The cells were then incubated with 5 µM CMFDA at 37˚C for 30 min. CMF fluorescence was assessed using a FACStar flow cytometer. Negative CMF staining (GSH-depletion) of cells is expressed as the percentage of (-) CMF cells.
Statistical analysis.
Results were the mean of at least two independent experiments (mean ± SD). Data were analyzed using GraphPad Prism4 software (GraphPad Prism, Inc., San Diego, CA, USA). Student's t-test or one-way analysis of variance with post hoc analysis using Tukey's multiple comparison test was used for parametric data. P<0.05 was considered to indicate a statistically significant difference.
Results

Effects of MAPK inhibitors on cell growth and death of H 2 O 2 -treated HeLa cells.
The effect of H 2 O 2 on the growth inhibitions of HeLa cells was examined using MTT assays. A concentration of 100 µM H 2 O 2 was considered sufficient to differentiate the levels of cell growth and death in the presence or absence of each MAPK inhibitor. Exposure to 100 µM H 2 O 2 for 24 h inhibited the growth of HeLa cells by ~70% (Fig. 1A) . None of the MAPK inhibitors significantly affected the growth inhibition induced by H 2 O 2 (Fig. 1A) . JNK and p38 inhibitors slightly reduced the growth of HeLa control cells (Fig. 1A) . Moreover, H 2 O 2 did not significantly affect HeLa cell cycle distribution (Fig. 1B) . While JNK and p38 inhibitors did not affect the cell cycle distribution of H 2 O 2 -treated HeLa cells, MEK inhibitor was found to increase the number of HeLa cells in the G1 phase of the cell cycle (Fig. 1B) . H 2 O 2 increased the number of HeLa cells in the sub-G1 phase by ~15% compared with H 2 O 2 -untreated HeLa control cells (Fig. 1C) . All the (Fig. 1D) . MAPK inhibitors were found to significantly increase the number of Annexin V-FITC-positive H 2 O 2 -treated HeLa cells (Fig. 1D) . Particularly, JNK inhibitor was found to exert a strong effect on cell death (Fig. 1C and D) . JNK inhibitor alone increased the number of Annexin V-FITC-positive HeLa control cells (Fig. 1D) . Cell death has been closely associated with the collapse of MMP (ΔΨ m ) (21) . As expected, loss of MMP (ΔΨ m ) was observed in H 2 O 2 -treated HeLa cells (Fig. 1E) . However, the percentage of cells with MMP (ΔΨ m ) loss was lower compared with that of Annexin V-FITC-positive cells. All the MAPK inhibitors slightly enhanced the loss of MMP (ΔΨ m ) in H 2 O 2 -treated HeLa cells, and JNK inhibitor exerted the most significant effect (Fig. 1E) . JNK or p38 inhibitor alone triggered MMP (ΔΨ m ) loss in HeLa control cells (Fig. 1E) . (Fig. 2) . Intracellular ROS (DCF) levels were increased in H 2 O 2 -treated cells at 1 (Fig. 1A ) and 24 h (Fig. 2D) . The MEK inhibitor appeared to attenuate the increased ROS (DCF) levels induced by H 2 O 2 treatment for 1 h (Fig. 2A) . The p38 inhibitor enhanced the increased ROS (DCF) levels induced by H 2 O 2 treatment for 1 ( Fig. 2A ) and 24 h (Fig. 2D) . The JNK inhibitor was found to significantly decrease ROS levels in HeLa control cells at 1 h, while the p38 inhibitor increased ROS levels in these cells at 1 ( Fig. 2A ) and 24 h (Fig. 2D) . Moreover, red fluorescence derived from DHE reflecting the intracellular O 2 •-levels was not altered in H 2 O 2 -treated HeLa cells at 1 h (Fig. 2B) , while it was significantly increased at 24 h of H 2 O 2 treatment (Fig. 2E) ) levels in HeLa control cells (Fig. 2E) . H 2 O 2 decreased GSH levels in HeLa cells at 1 h of treatment (Fig. 2C) as measured using a CMF fluorescence dye. All the MAPK inhibitors were shown to attenuate the decreased GSH levels induced by H 2 O 2 treatment for 1 h and to decrease the basal levels of GSH in HeLa control cells (Fig. 2C) . H 2 O 2 increased the percentages of GSH-depleted HeLa cells at 24 h of treatment by ~25% compared with the H 2 O 2 -untreated HeLa control cells (Fig. 2F) . MEK and p38 inhibitors were found to attenuate the depletion of GSH in H 2 O 2 -treated HeLa cells, and JNK inhibitor alone induced the depletion of GSH in HeLa control cells (Fig. 2F) . (Fig. 3A) . However, BSO did not affect cell growth of the H 2 O 2 -treated HeLa cells (Fig. 3A) . Only PG reduced the cell growth in HeLa control cells (Fig. 3A) . Concerning cell cycle analysis, NAC, PG or BSO did not alter the cell cycle distribution of H 2 O 2 -treated HeLa cells (Fig. 3B ). NAC and PG decreased the percentage of H 2 O 2 -treated HeLa cells in the sub-G1 phase, while BSO slightly increased the percentage in sub-G1 cells (Fig. 3C) . Notably, PG significantly increased the percentage of sub-G1 HeLa control cells (Fig. 3C) (Fig. 3D ). In addition, PG alone increased the percentage of Annexin V-FITC-positive HeLa control cells (Fig. 3D) . With respect to MMP (ΔΨ m ), PG decreased the loss of MMP (ΔΨ m ) induced by H 2 O 2 to some extent, while NAC and BSO did not significantly affect the loss of MMP (ΔΨ m ) (Fig. 3E) . PG also increased the percentage of HeLa control cells with MMP (ΔΨ m ) loss (Fig. 3E) . (Fig. 4A) . Additionally, PG and BSO significantly increased ROS (DCF) levels in HeLa control cells (Fig. 4A) . Similarly, NAC and PG decreased the augmented O 2
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µM). ROS and GSH levels in HeLa cells were measured using a FACStar flow cytometer. The graphs indicate DCF (ROS) levels (%) at (A) 1 and (D) 24 h; DHE (O 2 •-) levels (%) at (B) 1 and (E) 24 h; mean CMF (GSH) levels (%) at (C) 1 h and (F) (-) CMF (GSH-depleted) cells (%) at 24 h of treatment with
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•-levels in H 2 O 2 -treated HeLa cells, in contrast to BSO which increased O 2
•-levels (Fig. 4B ). Concerning assessment of the GSH levels, NAC appeared to reduce the percentage of GSH-depleted H 2 O 2 -treated HeLa cells, while PG did not affect the depletion of GSH (Fig. 4C) . PG alone significantly induced the depletion of GSH in HeLa control cells (Fig. 4C) . Notably, treatment with 10 µM BSO failed to enhance the depletion of GSH in H 2 O 2 -treated HeLa cells, which instead slightly attenuated GSH depletion in these cells (Fig. 4C) . ERK activation was observed in H 2 O 2 -treated HeLa cells (22) . In the present study, the MEK inhibitor, which presumably inactivates ERK, did not affect the H 2 O 2 -induced inhibition of HeLa cell growth, while it increased cell death. In addition, the MEK inhibitor alone increased the number of HeLa control cells in the sub-G1 phase of the cell cycle. Thus, ERK is likely to be associated with cell survival rather than cell death and proliferation. JNK and p38 MAPKs are known to be related to cell death (6,7). H 2 O 2 has been shown to increase the activity of JNK and p38 in HeLa cells (22, 23) . Yamagishi et al (23) demonstrated that HeLa cell apoptosis induced by 500 µM H 2 O 2 was suppressed by treatment with p38 inhibitor but not JNK inhibitor, suggesting that apoptosis occurs through a p38 MAPK-dependent signaling pathway. However, the results of the present study indicate that treatment with JNK and p38 inhibitors significantly increased the cell death of HeLa cells treated with 100 µM H 2 O 2 . These results suggest that JNK and p38 signaling pathways in HeLa cells treated with 100 µM H 2 O 2 are involved in a pro-survival function. The difference potentially resulted from the different concentrations and incubation times used in each experiment since the effects of MAPKs are altered by the different types of oxidative stress. JNK and p38 inhibitors significantly induced cell growth inhibition, cell death and MMP (ΔΨ m ) loss in HeLa control cells, indicating that the basal activities of these MAPKs are involved in the cell growth and survival of HeLa cells. PG is known to be a synthetic antioxidant (24, 25) , while it has been suggested to possess prooxidant properties (26) (27) (28) . Antioxidant and cytoprotective properties of PG may change to prooxidant, cytotoxic and genotoxic in the presence of Cu(II) (29) . According to a previous study, ROS levels, including O 2
Discussion
•-, were demonstrated to be increased or decreased in PG-treated HeLa cells depending on the incubation times and doses (19 Apoptotic effects are inversely proportional to GSH content (20, 30, 31) . Similarly, H 2 O 2 increased the percentages of GSH-depleted HeLa cells at 24 h of treatment. The JNK inhibitor and PG also significantly induced the depletion of GSH in HeLa control cells. These results support the hypothesis that the intracellular GSH content has a decisive impact on cell death (18, 20, 32 (30) and A549 cells (33) . Additional studies have shown that >100 µM BSO decreased GSH levels in breast cancer (34) and leukemia cells (35) . Therefore, these results suggest that BSO differentially affects GSH levels depending on the concentration used, the cell type and co-incubation drugs.
In conclusion, H 2 O 2 induced growth inhibition and death in HeLa cells, which was accompanied by intracellular increase in ROS levels and GSH depletion. MAPK inhibitors generally enhanced H 2 O 2 -induced HeLa cell death. Particularly, the p38 inhibitor increased ROS levels in H 2 O 2 -treated HeLa cells. NAC and PG attenuated H 2 O 2 -induced HeLa cell growth inhibition and death together with the suppression of ROS levels. The present study provides insight into the toxicological effects of exogenous H 2 O 2 on HeLa cells with respect to MAPK signaling and antioxidants.
